Publications by authors named "Bang-he Ding"

Objective: To observe the efficacy and safety of CLAE intensive chemotherapy followed by allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with relapsed/refractory acute leukemia (R/R AL).

Methods: CLAE regimen [cladribine 5 mg/(m·d), d 1-5; cytarabine 1.5 g/(m·d), d 1-5; etoposide 100 mg/(m·d), d 3-5] followed by allo-HSCT was used to treat 3 R/R AL patients.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how the CXCR4 gene influences the effectiveness of Carfilzomib (CFZ) treatment in patients with multiple myeloma (MM).
  • Researchers analyzed data from CFZ-resistant and parental MM cell lines to identify key genes related to CFZ resistance using microarray data and protein-protein interaction networks.
  • Findings reveal that high levels of CXCR4 expression are linked to increased relapse rates and decreased overall survival in MM patients, suggesting CXCR4 could be a target for improving treatment responses in resistant cases.
View Article and Find Full Text PDF

Objective: To investigate the efficacy and safety of micro-transplantation in acute myeloid leukemia (AML).

Methods: The clinical data of 13 adult AML patients who received micro-transplantation as consolidation therapy from July 2014 to October 2019 was retrospectively analyzed, and the adverse reactions and efficacy of micro-transplantation were followed up.

Results: Eight patients received micro-transpantation were still in complete remission, 5 patients relapsed after micro-transplantation, 1 of them received umbilical cord blood micro-transplantation after remission by reinduction, and all of the 13 patients have survived till now.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the importance of a targeted next-generation sequencing test for diagnosing myeloid malignancies in patients with blood disorders.
  • A total of 39 patients were analyzed, with 70.8% of those diagnosed with myeloid malignancies showing positive mutations, particularly in genes like ASXL1, TET2, and RUNX1.
  • The findings indicated that the targeted sequencing can enhance diagnosis and potentially guide treatment for patients, especially for those with myelodysplastic syndromes.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze clinical characteristics of 66 newly diagnosed essential thrombocytopenia (ET) patients, focusing on their mutation status (JAK2, CALR, MPL, or none).
  • Results showed that 69.7% had JAK2 mutations, with the average age significantly higher (63.2 years) than those with CALR mutations (51.8 years) or negative mutations (50.2 years).
  • The CALR mutation group exhibited lower white blood cell (WBC) and hemoglobin (Hb) levels, while 30.3% of all patients experienced thrombus or embolism, with some also facing complications like hyperkalemia.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the effectiveness and prognosis of acute myeloid leukemia (AML) patients based on chromosome karyotype abnormalities by investigating clinical features and treatment responses in 91 patients.
  • Results showed that while there was no significant difference in complete remission and overall response rates between patients with normal and abnormal karyotypes, those with abnormal karyotypes experienced higher recurrence rates and longer relapse-free survival for normal karyotype patients.
  • The conclusion drawn indicates that having an abnormal karyotype is an independent prognostic factor in AML, with a particular mention that monosomal karyotypes are associated with poorer outcomes and higher recurrence rates.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how combining inhibitors of mTORC2 and HSP90 affects the growth and death of multiple myeloma (MM) cells using the U266 cell line.
  • Treatment with rapamycin and 17-AAG showed that both drugs could slow down cell growth, with their combined use being more effective than each one alone or a control group.
  • The findings indicate that the combination therapy not only enhances apoptosis (cell death) but also alters key protein levels, suggesting a promising strategy for treating multiple myeloma.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore how the HSP90 inhibitor 17-AAG affects the growth of multiple myeloma cells (U266) and its underlying mechanisms.
  • Researchers treated U266 cells with various concentrations of 17-AAG over different time periods, measuring cell growth and the levels of specific proteins involved in cell proliferation.
  • Results showed that higher concentrations of 17-AAG significantly reduced cell growth and down-regulated key proteins (β-catenin and C-MYC), indicating that 17-AAG inhibits cell proliferation primarily through the Wnt/β-catenin signaling pathway and the inhibition of HSP90 expression.
View Article and Find Full Text PDF

Reduced-intensity (RIT) conditioning regimens are gaining increased attention as a result of their advantages and efficacy. However, no data are available regarding whether these regimens improve patient quality of life (QoL). In our study, health-related QoL (HRQoL) was retrospectively assessed in 111 patients with hematological malignancies.

View Article and Find Full Text PDF

This study was purposed to investigate the expression of Btk and NFκB in acute myeloid leukemia (AML) cells and its significance. Bone marrow mononuclear cell specimens were taken from 14 AML patients who were in new diagnosis and complete remission respectively, the expressions of Btk and NFκB at mRNA and protein levels were detected by RT-PCR and Western blot, respectively. The results showed that Btk and NFκB expressed in all the samples at RNA and protein levels.

View Article and Find Full Text PDF

Objective: To explore the risk factors for relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and the measures of prophylaxis and treatment.

Methods: We summarized the clinical data of 82 patients with hematologic malignancies who were treated in our hospital from August 2003 to December 2008. Factors including age, sex, ABO blood group disparity of donor and recipient as well as the type of donor, status of disease, HLA-match, conditioning regimen, whether or not having developed acute GVHD and chronic GVHD, infusion number of CD34(+) cells, relationship between CMV infection and relapse post-transplantation were considered and analyzed.

View Article and Find Full Text PDF

Background And Objective: Allogeneic hematopoietic cell transplantation (allo-HSCT) is a potent procedure for the treatment of hematologic diseases, yet it is associated with high risks of treatment-related complications. Except for transplant-related organ toxicities, renal insufficiencies which emerge earlier significantly limit patients' long survival. To analyze risk factors for acute kidney injury (AKI), we conducted a retrospective cohort study of 96 patients undergoing HSCT.

View Article and Find Full Text PDF

Objective: To observe the long-term effect of short interim high-dose dexamethasone (HD-DXM)in previously untreated patients affected by idiopathic thrombocytopenic purpura(ITP) and investigate the action of maintenance treatment.

Methods: 40 mg/d of dexamethasone was given in a 4-day pulse every 14 days for 3 cycles to 45 patients with ITP. Among them, 22 cases were given routinely dexamethasone of 0.

View Article and Find Full Text PDF

Background: Homoharringtonine (HHT) is effective in treating late stage chronic myelogenous leukaemia (CML), but little is known about long term maintenance during complete cytogenetic response. Long term efficacy and toxicity profiles of low dose HHT were evaluated in this study.

Methods: One hundred and six patients with CML received 1.

View Article and Find Full Text PDF

Objective: To explore the influence of methylprednisolone (MP) on cellular component in donor graft and on H-2 haploidentical hematopoietic stem cell transplantation (HSCT) in mice.

Methods: A murine model of H-2 haploidentical HSCT was established by using of c57BL/6J male mouse as donor and (c57BL/6J x LB/C) F1 female mouse as recipient. The donor mouse received peripheral-blood (PB) progenitor cells mobilization regimens consisted of recombinant human granulocyte colony-stimulating factor (rhGCSF) alone (control group) or combined with MP in dose of 2 mg/kg daily [small-dose (SD) group], 10 mg/kg daily [middle-dose (MD) group], and 50 mg/kg daily [large-dose (LD) group] respectively.

View Article and Find Full Text PDF

The aim of this study was to analyze the risk factors for overall survival at 5 years in 96 patients undergoing allogeneic hematopoietic stem cell transplantation by retrospective analysis. 11 clinical parameters including age, sex, disease status, HLA locus, donor type, donor-recipient blood type, conditioning regimen, aGVHD, HC, VOD and IP were selected for univariate analysis by using a Cox regression. Factors have statistic significance at the 0.

View Article and Find Full Text PDF